A Closer Look at Closed System Transfer Devices

Video
Conference|ASHP Summer

Fred Massoomi, PharmD, FASHP, senior director for Visante, discusses using closed system transfer devices.

Fred Massoomi, PharmD, FASHP, senior director for Visante, discusses using closed system transfer devices in creating a hazardous drug safety program, for compounding, and for administration.

Related Videos
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U - stock.adobe.com
Image credit: Andrea Izzotti
Inflation Reduction Act is shown using the text and the US flag - Image credit: Andrii | stock.adobe.com
3D illustration of heart
Model of a heart
Man experiencing heart pain
3D illustration of heart
Pharmacy Interior | Image Credit: Tyler Olson - stock.adobe.com
Related Content

Children Remain High Risk for Antiphospholipid Syndrome

November 23rd 2023

Pharmacy Focus: Conversations On Reproductive Health - Episode 1

November 15th 2023

Study: Pneumococcal Vaccines Do Not Prevent Development of Otitis Media in Infants

November 22nd 2023

Pharmacy Focus: Policy Edition - Navigating the Reimbursement Maze

November 13th 2023

CDC, FDA Announce 77,000 Additional Doses for Nirsevimab as Infant Treatment of RSV

November 22nd 2023

Pneumococcal Conjugate Vaccines Reduce Invasive Disease, Though Coverage Not Optimal

November 22nd 2023

Children Remain High Risk for Antiphospholipid Syndrome

November 23rd 2023

Pharmacy Focus: Conversations On Reproductive Health - Episode 1

November 15th 2023

Study: Pneumococcal Vaccines Do Not Prevent Development of Otitis Media in Infants

November 22nd 2023

Pharmacy Focus: Policy Edition - Navigating the Reimbursement Maze

November 13th 2023

CDC, FDA Announce 77,000 Additional Doses for Nirsevimab as Infant Treatment of RSV

November 22nd 2023

Pneumococcal Conjugate Vaccines Reduce Invasive Disease, Though Coverage Not Optimal

November 22nd 2023

Children Remain High Risk for Antiphospholipid Syndrome

November 23rd 2023

Pharmacy Focus: Conversations On Reproductive Health - Episode 1

November 15th 2023

Study: Pneumococcal Vaccines Do Not Prevent Development of Otitis Media in Infants

November 22nd 2023

Pharmacy Focus: Policy Edition - Navigating the Reimbursement Maze

November 13th 2023

CDC, FDA Announce 77,000 Additional Doses for Nirsevimab as Infant Treatment of RSV

November 22nd 2023

Pneumococcal Conjugate Vaccines Reduce Invasive Disease, Though Coverage Not Optimal

November 22nd 2023
© 2023 MJH Life Sciences

All rights reserved.